# Madrigal Pharmaceuticals, Inc.: Form 8-K, filed Jul 22, 2025

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: 8-K
- Filed: 2025-07-22
- Accepted by EDGAR: Jul 22, 2025, 08:29 ET
- Period: 2025-07-17
- Accession: 0001628280-25-035506
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000162828025035506/mdgl-20250717.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000162828025035506/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000162828025035506/mdgl-20250717.htm

Filed Jul 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-035506. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.